Thymosin beta-4 promotes corneal epithelial cell migration and proliferation through increased extracellular ATP, P2X7 receptor-mediated calcium influx, and ERK1/2 signaling.
P2X7purinergic receptor identified as key mediator of thymosin beta-4's corneal healing effects
What the researchers found
Tβ4-mediated corneal epithelial cell proliferation and migration are associated with increased extracellular ATP levels, P2X7 receptor-mediated calcium influx, and ERK1/2 phosphorylation. P2X7 antagonists blocked Tβ4-induced migration.
Why it matters
Understanding the signaling cascade behind Tβ4's corneal healing effects enables optimization of therapeutic formulations and identification of combination targets for enhanced corneal repair.
The numbers in context
TB4 increased extracellular ATP; P2 receptor blockade significantly reduced TB4-mediated cell migration.
How the study worked
In vitro studies on human corneal epithelial cells. Proliferation (CCK-8), gap closure migration assay, ATP measurement (ATP Lite kit), calcium imaging (Fluo 8 assay), P2X7 inhibitor studies, and Western blot for ERK1/2 phosphorylation.
Who was studied
Human corneal epithelial cells in culture
What this study cannot tell us
In vitro study on cultured human corneal epithelial cells — results may differ in the complex wound environment of a living eye. Specific P2X7 antagonist concentrations and their potential side effects not fully explored.
How to read the evidence
Solid in vitro mechanistic study with multiple complementary assays and receptor antagonist controls. Pre-clinical stage.
When this study was published
Published in 2020. Tβ4 continues to advance in clinical trials for corneal healing.
The bigger picture
Tβ4 is one of the most promising peptides for corneal healing, already in clinical trials. This mechanistic study fills a critical gap in understanding how it works, potentially enabling next-generation formulations that target multiple points in the healing cascade.
Questions still open
- Could P2X7 receptor agonists be used alongside Tβ4 to enhance corneal healing?
- Is the ATP-P2X7-ERK pathway also involved in Tβ4's effects in other tissues?
- How does this signaling cascade interact with the inflammatory response during corneal wound healing?
Common questions
What is purinergic signaling?
Why is thymosin beta-4 being developed for eye conditions?
Read the original research
Purinergic Signaling Involvement in Thymosin β4-mediated Corneal Epithelial Cell Migration.
Current eye research, 45(11), 1352-1358
Citation
Yang, Heung-Mo; Kang, Shin Wook; Sung, Jihye; Kim, Kyeongsoon; Kleinman, Hynda. (2020). Purinergic Signaling Involvement in Thymosin β4-mediated Corneal Epithelial Cell Migration.. Current eye research, 45(11), 1352-1358. https://doi.org/10.1080/02713683.2020.1748891